• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Boston Scientific settles Cordis stent war for $716 million

Boston Scientific settles Cordis stent war for $716 million

September 30, 2009 By MassDevice staff

Boston Scientific Corp. agreed to shell out $716 million to settle 14 patent infringement suits with Cordis Corp., closing a major front in the stent wars.

The Natick, Mass.-based medical device giant said it will pay the settlement in cash using a reserve set aside for one of the lawsuits.

The suits aren’t the only cases pending between BSX and Cordis parent Johnson & Johnson, but president and CEO Ray Elliott said Boston Scientific will continue to work on resolving the others.

The settled cases, involving lawsuits in U.S., Canadian, Belgian, German, French and Italian courts, include the so-called Palmaz-NIR suit, involving a patent by the radiologist who invented stents, Julio Palmaz.

The estimated settlement cost in that case would make up most of the $716 million nut to settle it and the other 13 suits.

Johnson & Johnson owns that patent and in 2000 won a lawsuit alleging that an early BoSci stent, the NIR, infringed the technology, according to the Wall Street Journal (paid). Boston Scientific appealed, but told investors last year that it expected that case to cost at least $703 million.

At least three other lawsuits between the stent colossi still have a pulse, including a Cordis suit over Boston Scientific’s Express, Taxus, Taxus Liberté, Promus and NIR stents and a Boston Scientific suit over Cordis’ Cypher drug-eluting stent.

The announcement is not the first big-ticket settlement between medical device leviathans. In July, Medtronic paid $444 million to arch-rival Abbott to settle a stent patent lawsuit.

Here’s a complete list of the cases in the latest settlement:

  1. Cordis Corp. v. Medtronic Vascular Inc., Boston Scientific Corp. et al.
  2. Johnson & Johnson Inc., Expandable Grafts Partnership & Cordis Corp. v. Boston Scientific Ltd./Boston Scientifique LTEE
  3. Johnson & Johnson Inc. v. Boston Scientific Ltd./Boston Scientifique LTEE
  4. Boston Scientific Corp. v. Johnson & Johnson
  5. Schneider (Europe) GmbH v. Johnson & Johnson Medical NV
  6. Schneider (Europe) GmbH v. Cordis Medizinische Apparate GmbH
  7. Schneider (Europe) GmbH v. Cordis
  8. Schneider (Europe) GmbH v. Johnson & Johnson Medical S.P.A.
  9. Cordis v. Schneider (damage request)
  10. Boston Scientific Scimed Inc. v. Cordis Corp.
  11. Boston Scientific Scimed Inc. v. Cordis Medizinische Apparate GmbH
  12. Boston Scientific Scimed Inc. v. Cordis Medizinische Apparate GmbH
  13. Scimed Life Systems Inc. v. Cordis Corp.
  14. Cordis Corp. v. Scimed Life Systems Inc.

Filed Under: Business/Financial News, Stents

More recent news

  • Imperative Care has positive stroke treatment study results
  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • Intuitive demonstrates remote telesurgery capabilities with da Vinci 5
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • CVRx announces Medicare win for Barostim therapy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy